personalized medicine? Pierre-Yves MARIE Department of Nuclear - - PowerPoint PPT Presentation
personalized medicine? Pierre-Yves MARIE Department of Nuclear - - PowerPoint PPT Presentation
Is myocardial-SPECT still a reference technique for CAD patients in the era of personalized medicine? Pierre-Yves MARIE Department of Nuclear Medicine CHU-Nancy, FRANCE. Is myocardial-SPECT still a reference technique for CAD patients in the
I - A remaining need of a personalized
functional information
Is myocardial-SPECT still a reference technique for CAD patients in the era of personalized medicine?
II - The future:
- new cameras and new tracers
- combining functional and
anatomic information.
I - A remaining need of a personalized
functional information
Is myocardial-SPECT still a reference technique for CAD patients in the era of personalized medicine?
II - The future:
- new cameras and new tracers
- combining functional and
anatomic information.
Anatomical information: is not enough for assessing CAD,
Multidetector CT
Coronary angiography
coronary atherosclerosis remains frequently:
- without ischemia,
- uncomplicated.
I - A remaining need of a personalized functional information
Multidetector CT
Coronary angiography
Autopsy studies have determined the rates of high grade coronary atherosclerosis in patients : (i) who were without any history of CAD (ii) who died because of a non-cardiac cause.
- 1. less than 25%
- 2. from 25 to 50%
- 3. more than 50%
What is this rate in > 65 years-old north-american male subjects?
Coronary atherosclerosis in diabetes mellitus A population-based autopsy study.
Tauqir Y. Goraya et al. J Am Coll Cardiol. 2002;40(5):946-53.
Prevalence of high-grade coronary atherosclerosis at autopsy by diabetes and clinical coronary disease status.
No CAD history D- D+ D+ D- CAD history D- D+ D+ D-
Short-axis apical median basal vertical horizontal Exercise
99mTc-sestamibi
Long-axis
Patient with a total occlusion of the right coronary artery, but with a normal exercise-SPECT under beta-blockers
Mechanisms:
- collaterals,
- antianginal medications.
Severe coronary stenoses are not always associated with severe perfusion abnormalities at exercise
I - A remaining need of a personalized functional information
Short-axis apical median basal vertical horizontal Exercise
99mTc-sestamibi
Long-axis
0% 10% 20% 30% 40%
Survival of 442 patients who had exercise SPECT under beta-blockers and their anti-anginal treatment
5 4 3 2 1
P<0.001
Years
Large necrosis (> 20% LV) Ischemia Neither ischemia nor large necrosis
Survival
1.0 .9 .8 .7 .6 .5 J Nucl Cardiol. 2003;10(4): 361-8.
J Nucl Cardiol 2003; 10:361-8.
I - A remaining need of a personalized functional information
Coronary flow insufficiency may occur in the absence of any > 50% stenosis at coronary angiography:
- abnormal flow reserve,
- exercise vasoconstriction.
Severe coronary stenoses are not always associated with severe perfusion abnormalities at exercise
I - A remaining need of a personalized functional information
Gage JE. Circulation. 1986;73:865
In intermediate stenoses, exercise ischemia may involves both:
- a limitation of coronary
flow reserve,
- vasoconstriction of
stenotic coronary segments.
40 patients with: [1] proven CAD (> 50% stenosis at angiography) and [2] positive exercise test
Eur J Nucl Med 2000 ;27(7):788-99.
Exercise Rest- reinjection Short-axis Dipyridamole Vertical long-axis apical mid-vent. basal . 72-year old man, angina and ST depression at exercise . 60 % stenosis on RCA
Exercise SPECT-defects are larger than dipyridamole SPECT- defects when ischemic areas are related to < 70% stenoses
(Eur J Nucl Med 2000 ;27(7):788-99).
Tl-201
Exercise Rest- reinjection Short-axis Dipyridamole Vertical long-axis apical mid-vent. basal . Exercise: angina, ST depression and 73% of maximal heart rate . Coronary angiography: dominant LCx: 80 %, intermediate branch: 90 % . Tl-201
Dipyridamole SPECT-defects are larger than exercise ones in patients with low exercise-increase in heart rate (β-blockers)
Eur J Nucl Med 2000 ;27(7):788-99.
Main parameters: Exercise testing parameters
(maximal work load and heart rate, positive test)
Normal stress-SPECT Extent of stress defects Extent of reversible stress
defects
Post-stress LV ejection fraction
(<45%) and end-systolic volume (>70 mL)
Reversible wall motion
abnormalities
Short-axis apical median basal Long-axis vertical horizontal
Function Exercise Rest Exercise Rest
Prognostic stratification using exercise MPI
Perfusion
Hachamovitch R, Circulation, 2003 Cardiac death rate (% per year)
Help in therapeutic decision according to the amount of ischemic area
Patients with prior MI (n=3,216)
% total myocardium ischemic Hazard ratio % total myocardium ischemic Hazard ratio
Patients with <10% MI (n=11,880)
Help in therapeutic decision according to the amount of ischemic area
Hachamovitch R, et al. Eur Heart J 2011;32:1012-1024: 13 969 patients followed at >7 years for all-cause death after stress SPECT (65% exercise) Hazard ratio for revascularization vs. medical therapy as a function of %myocardium ischaemic
Help in therapeutic decision according to the amount of ischemic area
Medical therapy Early revascularization % total myocardium ischemic Log Hazard ratio
Hachamovitch R, et al. Eur Heart J 2011;32:1012-1024: 13 969 patients followed at >7 years for all-cause death after stress SPECT (65% exercise) Log hazard ratio for revascularization vs. for medical therapy as a function of %myocardium ischaemic in patients with <10% necrotic myocardium
Cine-MRI Perfusion
Septal ischemia
- No radiation
- Highly accurate assessments of contractility and of MI areas
- Perfusion assessment with pharmacologic tests
I - A remaining need of a personalized functional information: is MRI a better choice than SPECT?
- specificity
(58% → 87%)
Klem I. et al. Improved detection of CAD by stress perfusion cardiovascular MR with the use of delayed enhancement infarction imaging. J Am Coll
- Cardiol. 2006;47:1630-8.
Delayed-enhancement imaging for increasing:
- sensitivity
(84% → 89%)
+ +
- Delayed
enhancement Stress perfusion Rest perfusion Coronary angiography
I - A remaining need of a personalized functional information: is MRI a better choice than SPECT?
Stress perfusion Abnormal Ischemia Rest perfusion Abnormal Normal DCE analysis Infarction Normal Abnormal No CAD (artifact)
Detection of CAD by perfusion-MRI with DCE analysis
Stress perfusion Rest perfusion Function (G.SPECT)
Detection of CAD by perfusion-SPECT with G.SPECT
Abnormal Ischemia Abnormal Normal Infarction Normal Abnormal No CAD (artifact)
Vi Viab able In Inte term rmediat ate Non vi viab able
(> 80% of further improvement) (≈ 50% of further improvement) (< 20% of further improvement )
0% 50% 100%
SPECT-tr trac acers rs ± nitrates % of
- f u
upta take > 60% 40-60% < 40% MRI : delayed retention Tra ransmura ral e exte tent < 25% 25-50% >50%
Viability assessment
I - A remaining need of a personalized functional information: is MRI a better choice than SPECT?
But MRI < SPECT for assessing stress ischemia:
- no assessment at exercise
- less safe
- more complex to perform and to analyze
- No radiation
- Highly accurate assessments of contractility and of MI areas
- Perfusion assessment with pharmacologic tests
II - The future:
- new cameras and new tracers
- combining functional and
anatomic information.
- ...
I - A remaining need of a personalized
functional information Physiological information on myocardial ischemia at exercise. Help in therapeutic decision.
Is myocardial-SPECT still a reference technique for CAD patients in the era of personalized medicine?
II - The future:
- new cameras and new tracers
- combining functional and
anatomic information.
- ...
I - A remaining need of a personalized
functional information Physiological information on myocardial ischemia at exercise. Help in therapeutic decision.
Is myocardial-SPECT still a reference technique for CAD patients in the era of personalized medicine?
Cadmium zinc telluride (CZT) solid-state detectors
- - much higher myocardial count rate
- - much higher energy resolution
- - higher spatial resolution
- - smaller size
GE Medical Systems Spectrum Dynamics
II - The future: solid-state detectors
++ ++++ ++ +
Performances of High-Sensitivity Cameras Imbert L. et al. 2012
II - The future: solid-state detectors
Discovery
- NM 530c
DSPECT IQSPECT Conventional
- SPECT
Phantom study Long-axis Short-axis
Comparison:
- between Discovery-NM530c and DSPECT CZT-cameras, and
Anger cameras with astigmatic or parallel-hole collimator,
- on SPECT images from phantoms and from normal subjects.
Clinical study Horizontal long-axis Median short-axis
Phantom study Clinical study
Sharpness index (cm-1) Spatial resolution (mm)
c r t
DSP NM IQ Conv DSP NM IQ Conv
*
c r t c r t c r t
* *
Performances of High-Sensitivity Cameras Imbert L. et al. 2012
II - The future: solid-state detectors
Comparison:
- between Discovery-NM530c and DSPECT CZT-cameras, and
Anger cameras with astigmatic or parallel-hole collimator,
- on SPECT images from phantoms and from normal subjects.
Spatial resolution
DSP NM IQ Conv DSP NM IQ Conv
* * * *
Contrast / noise ratio Contrast / noise ratio
Phantom study Clinical study
*
Performances of High-Sensitivity Cameras Imbert L. et al. 2012
Contrast
II - The future: solid-state detectors
Comparison:
- between Discovery-NM530c and DSPECT CZT-cameras, and
Anger cameras with astigmatic or parallel-hole collimator,
- on SPECT images from phantoms and from normal subjects.
Count sensitivity (count.sec-1.MBq-1) DSP NM IQ Conv
* * *
Phantom study Clinical study
DSP NM IQ Conv Normalized activity (count.sec-1.MBq-1)
Performances of High-Sensitivity Cameras Imbert L. et al. 2012
Count sensitivity
II - The future: solid-state detectors
Comparison:
- between Discovery-NM530c and DSPECT CZT-cameras, and
Anger cameras with astigmatic or parallel-hole collimator,
- on SPECT images from phantoms and from normal subjects.
Stress 2 min Rest 4 min Stress 11.5 min Rest 14 min Semi-conductors
Cadmium zinc telluride (CZT) solid-state detectors
- 6 to 10 fold increase in myocardial count rate
31
Inferior ischemia
For shortening recording times, up to 2 min for high injected activities,
Herzog BA et al. J Nucl Med. 2010;51:46-51 Gambhir SS, et al. J. Nucl. Med. 2009; 50(4):635–43. Sharir T, et al. JACC Cardiovasc
- Imaging. 2008;1(2):156–63.
Sharir T, al. J. Am. Coll. Cardiol. 2010; 55(18):1965–74.
High concordance with results from Anger cameras
II - The future: solid-state detectors
Conventional
Cadmium zinc telluride (CZT) solid-state detectors
- 6 to 10 fold increase in myocardial count rate
- - image quality and low-count artifacts
- especially in obese patients (A. Verger et al. 2012)
D.SPECT (4 min) Conventional (10 min)
Apical-SA Median-SA Basal-SA HLA VLA
Sestamibi SPECT in an obese patient
II - The future: solid-state detectors
for reducing injected activities, up to 110 MBq for
99mTc tracers,
Recording (2-3 min) Recording (7-10 min) 110 MBq of
99mTc tracer
330 MBq of
99mTc tracer
Stress / Rest Rest / Stress ~3 mSv for 99mTc tracer in non obese patients (≤ 1 mSv for only stress acquisition)
Cadmium zinc telluride (CZT) solid-state detectors
- 6 to 10 fold increase in myocardial count rate
Mouden M, et al. Eur J Nucl Med Mol Imaging. 2012
- Higher image quality and fewer equivocal results vs. Anger camera
Duvall WL, et al. J Nucl Cardiol. 2011;18(5):847-857. Gimelli A, et al. Eur J Nucl Med Mol Imaging. 2012; 39(1):83-90 Duvall WL, et al.J Nucl Cardiol. 2012;19(1):19-27.
- Accurate identification of patients with coronary stenosis
II - The future: solid-state detectors
for reducing injected activities, up to 50 MBq for 201Tl
Recording (7-10 min) 50 to 80 MBq
- f 201Tl
Stress Rest ~8 to 12 mSv for 201Tl in non obese patients
Cadmium zinc telluride (CZT) solid-state detectors
- 6 to 10 fold increase in myocardial count rate
Songy B, et al. Nucl Med Commun. 2012;33(5):464-9.
- Higher image quality and fewer artefacts vs. Anger camera
Songy B, et al. Nucl Med
- Commun. 2012;33(5):464-9.
Recording (7-10 min) 0 to 20 MBq
- f 201Tl
II - The future: solid-state detectors
for reducing injected activities
- r maximizing spatial and/or temporal resolutions?
Cadmium zinc telluride (CZT) solid-state detectors
- 6 to 10 fold increase in myocardial count rate
Sestamibi (400 MBq) 4 min recording time 16 frames / cycle voxels of 30 mm3
II - The future: solid-state detectors
Cadmium zinc telluride (CZT) solid-state detectors
- 6 to 10 fold increase in myocardial count rate
- much higher energy resolution
Dual energy recording
Camera recording (10-15 min) Stress
99mTc tracer
- r 201Tl
99mTc tracer
- r 201Tl
Rest Tl-201 Stress Sestamibi Inferior MI
II - The future: solid-state detectors
II - The future: hybrid SPECT/CT imaging
Low-radiation (≤ 2 mSv) CT recording might be useful for providing:
- 1. attenuation correction map (especially in
- bese subjects and in women…),
- 2. calcium score (enhanced prognosis
assessment of patients with normal SPECT),
- 3. coronary angiography (identifying
ischemia-related arteries).
Gaemperli O, Eur Heart J, 2006
CT-angiography for identifying ischemia-related arteries
II - The future: hybrid SPECT/CT imaging
II - The future: hybrid SPECT/CT imaging
M.P. Schenker, et al. Circulation. 2008;117(13):1693-700.
Calcium score for precising patient’s prognosis
risk increases independently according to calcium scores and PET ischemia.
PET+ patients PET- patients
CAC>1000 CAC>1000 CAC<1000 CAC<1000
Freedom from death and MI Freedom from death and MI Days to event
695 patients had stress-rest
82Ru-PET and calcium scoring
- n PET-CT
II - The future: other tracers
Dual 201Tl/123I-MIBG images with CZT-cameras
201Tl 201Tl 123I 123I
MIBG
Sever decrease in MIBG uptake in a diabetic patient (Leguludec D. Hôpital Bichat, Paris)
MIBG
Apoptosis with 99mTc-labeled annexin A5
DCM with rapid deterioration. Annexin uptake in apex and lateral wall.
Kietselaer BL, et al. J Nucl Med. 2007;48:562-7.
II - The future: other tracers
Apoptosis
Imaging of αvβ3 integrin using 18F-RGD in a rat infarct
Higuchi T, et al. Eur J Nucl Med Mol Imaging. 2007;34:S9-19.
Angiogenesis
II - The future: other tracers
MIBG
Apoptosis Angiogenesis Remodeling
Imaging of matrix metalloproteinase (MMP) in a mouse heart infarct.
Sinusas A. Yale University School of Medicine
II - The future: other tracers
MIBG
Apoptosis Angiogenesis Remodeling Inflammation
FDG in activated inflammatory cells
JOLY L et al. Eur J Nucl Med Mol Imaging. 2009;36(6):979.
In progress: many
- ther tracers such
as 18F-LP 17, a small agonist of TREM-1 receptors
II - The future: other tracers
MIBG
2) Promising for the future:
- technological jump related to new CZT cameras,
- combining SPECT information with the
anatomic information from low-dose CT,
- new tracers …
1) Particularly well adapted for providing a
physiological information on ischemia and for guiding treatments
Conclusion : myocardial-SPECT is still a reference technique for CAD patients in the era
- f personalized medicine